D-0040-2025 Class I Terminated
FDA drug recall D-0040-2025 was initiated by Staska Pharmaceuticals, Inc. on September 30, 2024 and is designated Class I. Reason for recall: Presence of Particulate Matter: Presence of glass particulates. The recall status is terminated (terminated August 5, 2025). Affected quantity: 4773 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- November 13, 2024
- Initiation Date
- September 30, 2024
- Termination Date
- August 5, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4773 vials
Product Description
Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317
Reason for Recall
Presence of Particulate Matter: Presence of glass particulates.
Distribution Pattern
Nationwide in the USA
Code Information
Lot #SP2400058, Exp 12/31/2024